SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-23-001524
Filing Date
2023-02-14
Accepted
2023-02-14 16:16:37
Documents
81
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 10-K organicell_10k.htm   iXBRL 10-K 2220264
2 EXHIBIT 10.61 organicell_ex10-61.htm EX-10.61 18200
3 EXHIBIT 10.62 organicell_ex10-62.htm EX-10.62 25350
4 EXHIBIT 10.63 organicell_ex10-63.htm EX-10.63 1958
5 EXHIBIT 23.1 organicell_ex23-1.htm EX-23.1 3301
6 EXHIBIT 31.1 organicell_ex31-1.htm EX-31.1 15773
7 EXHIBIT 32.1 organicell_ex32-1.htm EX-32.1 6332
13 GRAPHIC img_001.jpg GRAPHIC 69111
14 GRAPHIC ex10-63_001.jpg GRAPHIC 331257
15 GRAPHIC ex10-63_002.jpg GRAPHIC 396145
16 GRAPHIC ex10-63_003.jpg GRAPHIC 164147
  Complete submission text file 0001829126-23-001524.txt   10111766

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ocel-20221031.xsd EX-101.SCH 67279
9 XBRL CALCULATION FILE ocel-20221031_cal.xml EX-101.CAL 74362
10 XBRL DEFINITION FILE ocel-20221031_def.xml EX-101.DEF 253020
11 XBRL LABEL FILE ocel-20221031_lab.xml EX-101.LAB 430610
12 XBRL PRESENTATION FILE ocel-20221031_pre.xml EX-101.PRE 370010
75 EXTRACTED XBRL INSTANCE DOCUMENT organicell_10k_htm.xml XML 1078432
Mailing Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 000-55008 | Film No.: 23629568
SIC: 2836 Biological Products, (No Diagnostic Substances)